IL2 and systemic lupus erythematosus: The aim of this study is to conduct a head-to-head comparison between the 2 treatments and provide insights for clinical applications.<h4>Methods</h4>Lupus-prone mice were treated with umbilical cord-derived MSCs (UC-MSCs), IL-2, or a combination of UC-MSCs and IL-2, respectively.